GROUP ONE TRADING, L.P. - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 47 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 2.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q2 2020$14,000
-74.5%
10,249
-78.9%
0.00%
Q1 2020$55,000
-88.3%
48,486
-76.4%
0.00%
-100.0%
Q4 2019$469,000
+3808.3%
205,736
+1396.8%
0.00%
Q3 2019$12,000
-73.3%
13,745
-69.9%
0.00%
Q2 2019$45,000
-76.8%
45,602
-70.4%
0.00%
-100.0%
Q1 2019$194,000153,9930.00%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q1 2020
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders